Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiosurgery 58Radiotherapy 43Magnetic Resonance Spectroscopy 39Cyclophosphamide 34Standard of Care 30Surveys and Questionnaires 22Dexamethasone 19Educational Status 18Therapeutics 17Exercise 17Radiation 16Magnetic Resonance Imaging 16fludarabine phosphate 15Proton Therapy 15Practice Guidelines as Topic 15Methods 15Mammography 15Fluorodeoxyglucose F18 15Cisplatin 15Blood Specimen Collection 15Acupuncture Therapy 15Doxorubicin 14fludarabine 13Positron-Emission Tomography 13Calcium Dobesilate 13Biopsy 13Surgical Procedures, Operative 12Radiotherapy, Intensity-Modulated 12Palliative Care 12Indocyanine Green 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Has results × fluoromisonidazole × Clear all
NCT02016872 2025-04-30

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

Memorial Sloan Kettering Cancer Center

Phase NA Completed
25 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00606294 2023-06-28

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Memorial Sloan Kettering Cancer Center

Phase NA Completed
216 enrolled 9 charts
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡